New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free

Thursday, November 19, 2026

Back to the front page

From X

Serenity on X

Markets appear to be wrongly interpreting Chinese eSSD cuts as deteriorating demand and NAND oversupply. Phison CEO commentary today + more context behind $SNDK / Kioxia selloff regarding Trendforce revisions: - "Pua attributed China's recent enterprise SSD demand slowdown to GPU shortages since November 2026" - "Without GPUs, additional purchases offer little value, prompting some companies to sell server components on the spot market to recover cash" (for context enterprise SSDs are growth driver for NAND) - "Chinese cloud giants nevertheless plan substantial GPU prepayments, temporarily tying up capital and delaying procurement of other components." - "the principal challenge in 2027 would be insufficient supply rather than weakening demand, with persistent AI shortages potentially prompting further procurement and inventory accumulation." Markets seemed to have wrongly interpreted this as demand destruction + pricing collapse. When Phison CEO attributed it to -> GPU shortages -> causing procurement timing mismatch -> Chinese CSPs needed capital for GPU prepayments, so liquidation in inventory (causing spot price volatility) -> timeline shift in order procurement TLDR: delayed procurement from GPU shortages. there were actual order cuts, but this is deferred procurement not structural demand weakening. Chinese CSPs needed capital for GPU prepayments so they liquidated other inventories in the meantime. Phison says its inventories are insufficient for anticipated 2027 demand and it's sees this as an opportunity for NAND accumulation. It's interesting the bottleneck in China migrated back to GPUs though.

Problems at AMD (AMD)

AMD has committed up to $161.1 billion in customer equity rights and $33.1 billion in guarantees, leases and investments, while holding…

ANAB · long

Anaptysbio INC

AnaptysBio is pitched for a 50% to 80% return over four to six weeks after its April 2026 taxable spin-off of R&D-heavy operations.

Revisiting Veeva #2

Veeva plans Falcon agents for pharmacovigilance, clinical-trial documents and regulatory writing, targeting multibillion-dollar…

Performance Review: H1 2026

REIT holdings outperformed in H1 2026, with Veris Residential sold in a $19-per-share take-private and FrontView REIT trimmed after a 78%…

Over Target

Ukraine’s Black Sea attacks on CPC infrastructure threaten Kazakhstan’s 1.4 million bpd oil export route through Russia, putting Chevron’s…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

Seeking Alpha 98 of 301

X accounts we follow

Every account on this site, hand-picked.

94 accounts

Investor letters we follow

383 firms

Sectors

Ordered by how often our editor reaches for them.